IL-17 treatment possibly induced EMT in ovarian cancer cell lines via the expression of metastasis-associated genes-1 (MTA1) and targeting the IL-17/MTA-1 axis could be used as a treatment for ovarian cancer [38]. The gene discussed is MTA1; the disease is ovarian carcinoma.